For surveillance using ultrasound + AFP at real-world adherence rates, the most influential parameters were the proportion of HCC stage A in populations undergoing ultrasound + AFP, disease progression from compensated cirrhosis to developing liver masses, and the probability of an asymptomatic mass becoming symptomatic in compensated cirrhosis. Here, AFP is linked to hepatocellular carcinoma.